LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it is offering to sell 3,000,000 shares of its common stock in an underwritten public offering. It is currently anticipated that the underwriters will be granted an over-allotment option for an additional 450,000 shares.
